Curated News
By: NewsRamp Editorial Staff
July 15, 2026
LataMed AI Corp. Announces Effectiveness of 5-for-1 Forward Stock Split
TLDR
- LataMed AI's 5-for-1 forward stock split increases share count, potentially boosting liquidity and attracting more investors.
- LataMed AI executed a 5-for-1 forward stock split effective July 15, 2026, with a temporary symbol LMEDD reverting to LMED after 20 days.
- LataMed AI expands telemedicine and AI platforms to improve healthcare access in emerging markets, making tomorrow healthier.
- The temporary 'D' in LMEDD is a FINRA code for corporate actions, not a sign of distress—it's just a procedural tag.
Impact - Why it Matters
This news matters because the forward stock split and share exchange signal a strategic move by LataMed AI to restructure its capital and potentially increase liquidity and marketability of its shares. For investors, this corporate action may affect share price and trading volume, making it crucial to understand the new CUSIP and temporary symbol. The company's continued focus on AI-driven healthcare platforms like CardioAI, PulmoAI, and NeuroAI underscores its commitment to emerging markets, which could impact healthcare access in underserved regions. Shareholders should monitor the transition period and ensure their holdings are correctly processed.
Summary
LataMed AI Corp. (OTC: LMEDD) has announced the effectiveness of its previously announced 5-for-1 forward stock split, effective at the opening of trading on July 15, 2026, following publication on the FINRA Daily List. The company's common stock will temporarily trade under the symbol LMEDD, with the 'D' designation expected to remain for approximately 20 business days before reverting to LMED. The forward split is implemented alongside a mandatory share exchange and a new CUSIP number, 21116R404, replacing the old CUSIP 21116R305. Shareholders holding shares through brokerage accounts or in electronic book-entry form generally need not take any action, as the corporate action will be processed automatically. Those with physical certificates are not required to immediately surrender them but will be handled under mandatory exchange procedures when presented for transfer, sale, or exchange.
Dr. Kevin Rodan Levy, CEO of LataMed AI Corp., highlighted that the forward stock split marks an important corporate milestone. The company is focused on expanding its telemedicine platform and pursuing commercialization opportunities for its CardioAI, PulmoAI, and NeuroAI artificial intelligence platforms. LataMed AI is a development-stage digital health and AI technology company building telehealth infrastructure, healthcare coordination tools, and AI-enabled solutions for emerging markets, with an initial focus on Latin America. The company's strategy includes developing technology platforms to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, and payment solutions.
Investors and shareholders with questions regarding the exchange process are encouraged to contact their brokerage firm or LataMed AI's transfer agent. For additional information, the company directs to its website at https://latamed.ai, official social media channels, and SEC filings at www.sec.gov. The press release also includes forward-looking statements with standard cautionary language about risks and uncertainties. The original release can be viewed on NEWMEDIAWIRE.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, LataMed AI Corp. Announces Effectiveness of 5-for-1 Forward Stock Split
